Results 71 to 80 of about 4,823 (126)

Detección fenotípica de metalobetalactamasas en aislados clínicos de Pseudomonas aeruginosa

Kasmera, 2012
: Pseudomonas aeruginosa is considered one of the most important hospital germs; its isolation is common in hospitalized patients. In addition, this microorganism has a marked multiresistance, which increases mortality.
Perozo-Mena Armindo José, Castellano-González Maribel Josefina, Ling-Toledo Eliana, Arraiz Nailet   +3 more
doaj  

Carbapenem-Hydrolyzing Metallo-ß-Lactamase from a Nosocomial Isolate of Pseudomonas aeruginosa in France

Emerging Infectious Diseases, 2000
Laurent Poirel, Louis Collet, P. Nordmann   +2 more
doaj   +1 more source

Model-Informed Precision Dosing of Imipenem in an Obese Adolescent Patient with Augmented Renal Clearance and History of Schizophrenia

Infection and Drug Resistance
Yueliang Chen,1,* Yun Han,2,3,* Feng Guo,1 Zhenwei Yu2,3 1Intensive Care Unit, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Pharmacy, Sir Run Run Shaw Hospital,
Chen Y, Han Y, Guo F, Yu Z
doaj  

Imipenem [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Corrigendum: Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

Frontiers in Pharmacology
Jing Wang, Qiu Fang, Xuemei Luo, Lu Jin, Huaijun Zhu, Huaijun Zhu   +5 more
doaj   +1 more source

Mycobacterium setense Infection in Humans

Emerging Infectious Diseases, 2008
Alexandre Toro, Toidi Adekambi, François Cheynet, Pierre-Edouard Fournier, Michel Drancourt   +4 more
doaj   +1 more source

Imipenem.

Indian pediatrics, 2002
K K, Locham, Manpreet, Sodhi, Dhiraj, Sarwal   +2 more
openaire   +3 more sources

Correction: Multifactorial resistance mechanisms associated with resistance to ceftazidime-avibactam in clinical Pseudomonas aeruginosa isolates from Switzerland

Frontiers in Cellular and Infection Microbiology
Baharak Babouee Flury, Baharak Babouee Flury, Baharak Babouee Flury, Anja Bösch, Anja Bösch, Valentin Gisler, Valentin Gisler, Adrian Egli, Salome N. Seiffert, Oliver Nolte, Jacqueline Findlay   +10 more
doaj   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Imipenem

Mayo Clinic Proceedings, 1991
Imipenem is the first of a new class of beta-lactam antibiotics, the carbapenems, to be released for clinical use. It has the broadest antibacterial activity of all antibiotics available for systemic use in humans. It is active against streptococci, methicillin-sensitive staphylococci, Neisseria, Haemophilus, anaerobes, and the common aerobic gram ...
W C, Hellinger, N S, Brewer
  +5 more sources

Imipenem and Aztreonam

Infectious Disease Clinics of North America, 1989
To date, clinical use of aztreonam has been remarkably restrained and widespread enthusiasm for addition to hospital formularies similarly moderate. Its most accepted indication appears to be in gram-negative bacillary infections in the penicillin-allergic individual where one might ordinarily use an extended spectrum penicillin or a third generation ...
openaire   +2 more sources